Rubric Assessments (626384)
Assessment | Metrics | Date | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Target | Project | Contact information is provided for the creator(s) of the dataset. | Globally unique identifier | Machine-readable metadata | Standardized metadata | Resource identifier in metadata | Open, Free, Standardized Access protocol | Digital resource license | Metadata license | NIH program name is available for querying | NIH project name is available for querying | The institution that created this dataset is available | A biological assay is present and resolvable in CFDE-specified ontology (OBI) | A relevant anatomical part is present and resolvable in the UBERON Ontology | A relevant disease is present and resolvable in the MONDO Ontology | A relevant file type is present and resolvable in the EDAM Ontology | A relevant taxonomy is present and resolvable in the NCBITaxon Ontology | A relevant cell line is present and resolvable in the Cellosaurus Ontology | A landing page exists and is accessible | ||
MEMA HMEC122L Staining Set 4 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
JNK-IN-8 KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
iMN (Exp 2) - ALS, SMA and Control (unaffected) iMN cell lines differentiated from iPS cell lines using a long differentiation protocol - Proteomics | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
AZ-628 KiNativ -- dose response experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
MEMA HMEC122L Staining Set C | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Transcriptomics dataset (August 2015) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Sorafenib KiNativ -- dose response experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Average variable importance in the projection (VIP) scores from the PLSR models analyzing the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Tyrosine Kinase Inhibitor-induced cardiotoxicity in hiPSC derived cardiomyocytes - pilot dataset | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
PLSR model loadings (pMEK and pERK included) from analysis of the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
MEMA HMEC240L Staining Set 1 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
QL-X-138 KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
PCI-32765 KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
BMS345541 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Buparlisib KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
A770041 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
AMG-706 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
BMS-345541 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 2 of 2: Calculated dose response metrics | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yesbut (0.72) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
CGP082996 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
CH5424802 KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yesbut (0.76) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Basal profile of receptor tyrosine kinase signaling network measured by ELISA | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.84) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
Breast Cancer Deubiquitinating Enzyme (DUB) Inhibitor Profiling: Fixed-cell GR measures of 21 breast cell lines to 32 small molecule perturbagens. Dataset 2 of 2: Calculated dose response metrics. | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
AT-7519 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 |